SCTbio

SCTbio is a European global contract development and manufacturing organization for Advanced Therapy Medicinal Products (ATMPs). Founded in July 2021 as a spin-off from SOTIO, member of PPF Group, to directly address the growing demand for cell and gene therapy manufacturing, SCTbio holds over a decade of experience developing best-in-class clinical manufacturing services, development solutions and technologies transfer.